Skip to main content

Table 1 Difference between mild and severe patients based on initial symptom and serum biochemical examination

From: Predictive factors of severe coronavirus disease 2019 in previously healthy young adults: a single-center, retrospective study

Variables

All (n = 123)

Mild (n = 95)

Severe (n = 28)

P

Characteristic

 Age (years)

37 (7)

35 (6)

39.5 (5.35)

0.019

 Sex (male)

55/123 (44.7%)

38/95 (40%)

17/28 (60.7%)

0.053

Signs and symptoms

 Temp(°C)

38.20 (0.80)

38.10 (0.8)

38.50 (0.50)

0.036

 Time pre-adm (days)

6 (4)

7 (4)

6.00 (2.50)

0.297

 Fever

98/123 (79.7%)

71/95 (74.7%)

27/28 (96.4%)

0.012

 Cough

79/123 (64.2%)

64/95 (67.4%)

15/28 (53.6%)

0.181

 Expectoration

32/123 (26%)

23/95 (24.2%)

9/28 (32.1%)

0.400

 Headache

19/123 (15.4%)

15/95 (15.8%

4/28 (14.3%)

0.847

 Wheeze

24/123 (19.5%)

18/95 (18.9%)

6/28 (21.4%)

0.771

 Weakness

50/123 (40.7%)

36/95 (37.9%)

14/28 (50%)

0.252

 Muscle ache

31/123 (25.2%)

25/95 (26.3%)

6/28 (21.4%)

0.601

 Pharyngalgia

12/123 (9.8%)

9/95 (9.5%)

3/28 (10.7%)

0.846

 Runny nose

2/123 (1.6%)

2/95 (2.1%)

0/28 (0%)

0.439

 Anorexia

59/123 (48.0%)

38/95 (40%)

21/28 (75%)

0.001

 Stethalgia

10/123 (8.1%)

9/95 (9.5%)

1/28 (3.6%)

0.315

 Chest Tightness

39/123 (31.7%)

28/95 (29.5%)

11/28 (39.3%)

0.327

 Dyspnea

7/123 (5.7%)

5/95 (5.3%)

2/28 (7.1%)

0.706

 Diarrhea

13/123 (10.6%)

9/95 (9.5%)

4/28 (14.3%)

0.467

 CT Bilateral Lesion

84/123 (68.3%)

63/95 (66.3%)

21/28 (75%)

0.385

 Preadmission Drugs

49/123 (39.8%)

40/95 (42.1%)

9/28 (32.1%)

0.344

Serum Biomarkers

 WBC(109/L)

4.85 (1.04)

5.01 (0.93)

3.97 (1.37)

0.048

 RBC(109/L)

4.49 (0.40)

4.47 (0.39)

4.69 (0.45)

0.102

 N%

63.77 (15.16)

61.99 (13.93)

69.81 (17.72)

0.016

 N(109/L)

2.96 (0.89)

3.01 (0.77)

2.57 (1.81)

0.563

 L(109/L)

1.22 (0.41)

1.30 (0.56)

0.80 (0.36)

< 0.001

 PLT(109/L)

173 (39)

184 (42)

157.50 (23.00)

0.016

 CRP (mg/dL)

0.58 (1.66)

0.46 (0.93)

1.46 (2.58)

< 0.001

 Cr (umol/L)

64.50 (8.30)

63.30 (9.20)

66.35 (10.63)

0.433

 BUN (mmol/L)

3.62 (0.58)

3.62 (0.56)

3.83 (1.23)

0.173

 AST(U/L)

20.00 (6.20)

19.00 (6.30)

22.45 (11.83)

0.037

 ALT(U/L)

18.50 (11.20)

17.70 (12.00)

24.05 (7.78)

0.094

 TBIL (umol/L)

8.80 (3.40)

8.80 (2.60)

8.65 (3.80)

0.686

 DBIL (umol/L)

3.00 (0.90)

3.00 (0.80)

3.05 (1.43)

0.319

 IBIL (umol/L)

5.60 (2.60)

5.60 (2.60)

5.75 (3.43)

0.959

 ALB(g/L)

41.96 (4.62)

42.42 (4.48)

40.40 (4.82)

0.042

 CK(U/L)

67 (51)

64.50 (45.75)

92.00 (106.00)

0.011

 CK-MB(U/L)

7.00 (3.00)

6.90 (3.70)

8.00 (2.00)

0.243

 D-dimer (mg/dL)

0.32 (0.28)

0.30 (0.46)

0.37 (0.15)

0.574

 PT(s)

16.20 (0.60)

16.20 (0.60)

15.8 (1.20)

0.330

 INR

0.98 (0.07)

0.99 (0.07)

0.98 (0.07)

0.414

 Fib(g/L)

2.52 (0.42)

2.50 (0.30)

2.75 (0.76)

0.001

  1. All data are expressed as n (%), median (interquartile range), and mean (standard deviation). The missing date: CRP, PT, INR and Fib (mild 1case, severe 1case), CK and CK-MB (mild 3 cases, severe 1case), D-dimer (mild 0 cases, severe 1case). Where N is the total number of patients with available data. P values comparing mild and severe are from χ2 or Mann-Whitney U test. ALB albumin, ALT alanine transaminase, AST aspartate transaminase, BUN blood urea nitrogen, CK creatine kinase, CK-MB creatine kinase isoenzyme, Cr creatinine, CRP C-reactive protein, DBIL direct bilirubin, Fib fibrinogen, IBIL, indirect bilirubin, INR international normalized ratio, L lymphocyte count, N neutrophil count, N% neutrophil%, PLT platelet, PT prothrombin time, RBC red blood cell, TBIL total bilirubin, Temp temperature, WBC white blood cell